Cited by 307Microbial Metabolites in Food BiotechnologyGut microbiota and healthProbiotics and Fermented Foods

Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials

Open access
Kellow, Nicole J., Coughlan, Melinda T., Reid, Christopher M.·2014·British Journal of Nutrition

Abstract

Complex relationships exist between the gut microflora and their human hosts. Emerging evidence suggests that bacterial dysbiosis within the colon may be involved in the pathogenesis of the metabolic syndrome, type 2 diabetes and CVD. The use of dietary prebiotic supplements to restore an optimal balance of intestinal flora may positively affect host metabolism, representing a potential treatment strategy for individuals with cardiometabolic disorders. The present review aimed to examine the current evidence supporting that dietary prebiotic supplementation in adults has beneficial effects on biochemical parameters associated with the development of metabolic abnormalities including obesity, glucose intolerance, dyslipidaemia, hepatic steatosis and low-grade chronic inflammation. Between January 2000 and September 2013, eight computer databases were searched for randomised controlled trials published in English. Human trials were included if at least one group received a dietary prebiotic intervention. In the present review, twenty-six randomised controlled trials involving 831 participants were included. Evidence indicated that dietary prebiotic supplementation increased self-reported feelings of satiety in healthy adults (standardised mean difference − 0·57, 95 % CI − 1·13, − 0·01). Prebiotic supplementation also significantly reduced postprandial glucose ( − 0·76, 95 % CI − 1·41, − 0·12) and insulin ( − 0·77, 95 % CI − 1·50, − 0·04) concentrations. The effects of dietary prebiotics on total energy intake, body weight, peptide YY and glucagon-like peptide-1 concentrations, gastric emptying times, insulin sensitivity, lipids, inflammatory markers and immune function were contradictory. Dietary prebiotic consumption was found to be associated with subjective improvements in satiety and reductions in postprandial glucose and insulin concentrations. Additional evidence is required before recommending prebiotic supplements to individuals with metabolic abnormalities. Large-scale trials of longer duration evaluating gut microbial growth and activity are required.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114513003607

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prebiotic fiber improves cardiometabolic risk factors.

    “However, these products dually lack the addition of prebiotic fiber-which improves cardiometabolic risk factors (14,15), and include non-nutritive synthetic sweeteners-which are contraindicated for weight management and chronic disease risk (16).”

    From Prebiotic soda lowers postprandial glucose compared to traditional soda pop: a randomized controlled trial (2025) · cites this paper as [14]

    The Abstract and the section on glucose intolerance report reductions in postprandial glucose and insulin after prebiotic supplementation. But the Abstract says findings for other cardiometabolic measures, including body weight, insulin sensitivity and lipids, were contradictory. The unqualified claim that prebiotic fiber improves cardiometabolic risk factors is therefore broader than the review supports. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Havenaar R (2011) Intestinal health functions of colonic microbial metabolites: a review. Benef Microbes 2, 103-114.
  2. Heyland DK, Novak F, Drover JW, et al. (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286, 944 -953.

Cited by

Sorted by citations

Authors
Kellow, N. J., Coughlan, M. T., & Reid, C. M.
Affiliations
  • Monash University (AU)
  • Baker Heart and Diabetes Institute (AU)
Corresponding author
Kellow, Nicole J.
Venue
British Journal of Nutrition
Published
2013-11-13
Volume
111
Issue
7
Pages
1147-1161
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
OpenAlex
W2136653243
Cited by
307
References
11
Citations by year
2026: 16 · 2025: 21 · 2024: 17 · 2023: 20 · 2022: 26 · 2021: 24 · 2020: 29 · 2019: 33 · 2018: 26 · 2017: 30 · 2016: 21 · 2015: 33 · 2014: 10
FWCI
2.41
Type
journal article
Language
en
Open access
Locations
  • British Journal Of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • eSpace (Curtin University) (submittedVersion)
Funders
  • Medical Research Council
  • National Health and Medical Research Council (1039709)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
dietary prebiotics, prebiotic supplementation, gut microbiota, metabolic syndrome, type 2 diabetes, obesity, impaired glucose tolerance, postprandial blood glucose, insulin, satiety, dyslipidemia, hepatic steatosis, low-grade inflammation, cardiometabolic disease, insulin sensitivity, peptide YY, glucagon-like peptide-1, gastric emptying
MeSH terms
Adult, Animals, Health Promotion, Humans, Hyperglycemia, Hyperinsulinism, Intestines, Satiety Response, Reproducibility of Results, Randomized Controlled Trials as Topic, Postprandial Period, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review